Table of Content




1. Introduction


2. Research & Methodology

3. Executive Summary


4. Market Dynamics

4.1 Growth Driver

4.1.1 Rising Diabetes Mellitus in an Aging Population
4.1.2 Rising prevalence of diabetes in various age groups
4.1.3 Rising Government Funding for Diabetes Management
4.1.4 Benefits of Insulin Pump over Multiple Daily Injection
4.1.5 Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices

4.2 Challenges

4.2.1 Technological advancements in insulin infusion devices
4.2.2 Blood Glucose Meter Accuracy Problem
4.2.3 Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies
4.2.4 Safety Issues in Insulin Pump Devices
4.2.5 Difficulties Associated with the Pump
4.2.6 Adherence


5. United States Diabetes Market


6. United States Diabetes Population & Forecast

6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
6.3 Type 1 & Type 2 Diabetes Population and Forecast


7. Market Share Analysis – United States Diabetic

7.1 By Types


8. Continuous Glucose Monitoring Market (CGM) – Market & Users

8.1 CGM Market by Components

8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market

8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in United States


9. Blood Glucose Device (SMBG) – United States Market & Users

9.1 Market

9.1.1 Type 1 & Type 2 (Diabetes) SMBG Market

9.2 Test Strips Market

9.2.1 Type 1 & Type 2 (Diabetes)

9.3 Lancet Market and Forecast

9.3.1 Type 1 & Type 2 (Diabetes)

9.4 Meter Market and Forecast

9.4.1 Type 1 & Type 2 (Diabetes)

9.5 Blood Glucose (SMBG) Users

9.5.1 Type 1 & Type 2 (Diabetes)

9.6 Reimbursement Policies of Blood Glucose Devices in United States


10. Insulin Pen – United States Market & User

10.1 Insulin Pen User

10.1.1 Disposable Insulin Pen
10.1.2 Reusable Insulin Pen
10.1.3 Smart Insulin Pen

10.2 Insulin Pen Market

10.2.1 Disposable Insulin Pen
10.2.2 Reusable Insulin Pen
10.2.3 Smart Insulin Pen

10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies of Insulin Pen in United States


11. Insulin Pump - United States Market & Users

11.1 Insulin Pump Market for Type 1 Diabetes
11.2 Insulin Pump Market for Type 2 Diabetes
11.3 Insulin Pump User

11.3.1 Insulin Pump User & Forecast
11.3.2 Type 1 & Type 2 (Insulin Pump User & Forecast)

11.4 Differentiation Points of Insulin Pump Products in United States

11.4.1 Animas Vibe
11.4.2 Medtronic 530G with Enlite
11.4.3 Insulet OmniPod
11.4.4 Tandem t: slim
11.4.5 Roche Accu-Chek Combo

11.5 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care11.5.1 Medtronic
11.6 Insulet Corporation

11.6.1 Training Structure for New Patients - Insulet Corporation

11.7 Animas Corporation

11.7.1 Training Modules for New Patients
11.7.2 Training Modules for HCP (Health Care Professional)

11.8 Tandem Diabetes Care
11.9 USA (By States) – Diabetes Supplies, Insulin Pump & Pump Supplies Reimbursement Policies by State-Sponsored Health Program

11.9.1 CALIFORNIA
11.9.2 People Covered by Insurance Mandates
11.9.3 Equipment and Supplies
11.9.4 Services
11.9.5 DELAWARE
11.9.6 FLORIDA
11.9.7 MASSACHUSETTS
11.9.8 MICHIGAN
11.9.9 MONTANA
11.9.10 NEBRASKA
11.9.11 NEW JERSEY
11.9.12 NEW YORK
11.9.13 OKLAHOMA
11.9.14 RHODE ISLAND
11.9.15 SOUTH DAKOTA
11.9.16 Equipment and Supplies
11.9.17 Services

11.10 TENNESSEE

11.10.1 People Covered by Insurance Mandates
11.10.2 Equipment and Supplies
11.10.3 Services

11.11 TEXAS

11.11.1 People Covered by Insurance Mandates
11.11.2 Equipment and Supplies
11.11.3 Services:

11.12 WASHINGTON

11.12.1 People Covered by Insurance Mandates
11.12.2 Equipment and Supplies
11.12.3 Services

11.13 Top Private Insurer - Reimbursement Policy of Insulin Pump

11.13.1 Blue Cross and Blue Shield
11.13.2 Insulin Pump Reimbursement

11.14 Aetna

11.14.1 Insulin Pump Reimbursement

11.15 Cigna

11.15.1 Insulin Pump Coverage Policy

11.16 United Healthcare

11.16.1 Insulin Pump Reimbursement Policy


12. Insulin Pen – Company Analysis

12.1 B. Braun Melsungen AG

12.1.1 Overview
12.1.2 Initiatives & Recent Developments
12.1.3 Revenue

12.2 Eli Lilly

12.2.1 Overview
12.2.2 Initiatives & Recent Developments
12.2.3 Revenue

12.3 Artsana S.p.A.,

12.3.1 Overview
12.3.2 Initiatives & Recent Developments
12.3.3 Revenue

12.4 BD

12.4.1 Overview
12.4.2 Initiatives & Recent Developments
12.4.3 Revenue

12.5 Novo Nordisk A/S

12.5.1 Overview
12.5.2 Initiatives & Recent Developments
12.5.3 Revenue

12.6 Owen Mumford Ltd.

12.6.1 Overview
12.6.2 Initiatives & Recent Developments
12.6.3 Revenue

12.7 Ypsomed AG

12.7.1 Overview
12.7.2 Initiatives & Recent Developments
12.7.3 Revenue


13. Insulin Pump – Company Analysis

13.1 Medtronic

13.1.1 Overview
13.1.2 Insulin Pump – Product Details
13.1.3 Revenue
13.1.4 Insulin Pump – Latest Development & Trends

13.2 Insulet Corporation

13.2.1 Overview
13.2.2 Insulin Pump – Product Details
13.2.3 Revenue

14. SMBG – Company Analysis

14.1 LifeScan Inc.

14.1.1 Overview
14.1.2 LifeScan SMBG Revenue& Forecast

14.2 Abbott Laboratories

14.2.1 Business Overview
14.2.2 Abbott Laboratories SMBG Revenue & Forecast

15. CGM – Company Analysis

15.1 Dexcom Inc

15.1.2 Recent Development
15.1.3 Revenue& Forecast

15.2 Abbott Laboratories

15.2.1 Overview
15.2.2 Recent Development

15.3 Roche

15.3.1 Overview
15.3.2 Recent Development



List of Figures



Figure 4-1: Global Ageing Population (Billion) 2015 – 2050
Figure 5-1: United States –Diabetic Market (Billion US$), 2013 – 2019
Figure 5-2: United States– Forecast for Market (Billion US$), 2020 – 2025
Figure 6-1: United States – Diabetic Population (Thousand), 2013 – 2019
Figure 6-2: Global – Forecast for Diabetic Population (Thousand), 2020 – 2025
Figure 6-3: United States – Type 1 & Type 2 Diabetes Population (Thousand), 2011 – 2019
Figure 6-4: United States – Forecast for Type 1 & Type 2 Diabetes Population (Thousand), 2020 – 2025
Figure 8-1: United States – CGM Market (Million US$), 2011 – 2019
Figure 8-2: United States – Forecast for CGM Market (Million US$), 2020 – 2025
Figure 8-3: United States – Glucose Sensor Market (Million US$), 2011 – 2019
Figure 8-4: United States – Forecast for Glucose Sensor Market (Million US$), 2020 – 2025
Figure 8-5: United States – CGM Transmitter Market (Million US$), 2011 – 2019
Figure 8-6: United States – Forecast for CGM Transmitter Market (Million US$), 2020 – 2025
Figure 8-7: United States – CGM User (Number), 2011 – 2019
Figure 8-8: United States – Forecast for CGM User (Number), 2020 – 2025
Figure 9-1: United States - Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2011 – 2019
Figure 9-2: United States - Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2020 – 2025
Figure 9-3: United States - Self-Monitoring of Blood Glucose Market by Type 1 & Type 2
Figure 9-4: United States - Forecast for Self-Monitoring of Blood Glucose Market Type 1 & Type 2
Figure 9-5: United States - Blood Glucose Test Strips Market (Million US$), 2011 – 2019
Figure 9-6: United States - Forecast for Blood Glucose Test Strips Market (Million US$), 2020 – 2025
Figure 9-7: United States - Blood Glucose Test Strips Market by Type 1 & Type 2
Figure 9-8: United States - Forecast for Blood Glucose Test Strips Market by Type 1 & Type 2
Figure 9-9: United States - Blood Glucose Lancet Market (Million US$), 2011 – 2019
Figure 9-10: United States - Forecast for Blood Glucose Lancet Market (Million US$), 2020 – 2025
Figure 9-11: United States - Blood Glucose Lancet Market by Type 1 & Type 2
Figure 9-12: United States - Forecast for Blood Glucose Lancet Market by Type 1 & Type 2
Figure 9-13: United States - Blood Glucose Meter Market (Million US$), 2011 – 2019
Figure 9-14: United States - Forecast for Blood Glucose Meter Market (Million US$), 2020 – 2025
Figure 9-15: United States - Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2011 – 2019
Figure 9-16: United States - Forecast for Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9-17: United States - Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2011 – 2019
Figure 9-18: United States - Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2020 – 2025
Figure 9-19: United States - Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2011 – 2018
Figure 9-20: United States - Forecast for Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2019 – 2025
Figure 10-1: United States – Insulin Pen Market (Million US$), 2011 – 2019
Figure 10-2: United States – Forecast for Insulin Pen Market (Million US$), 2020 – 2025
Figure 10-3: United States – Insulin Pen Users (Numbers), 2011 – 2019
Figure 10-4: United States – Forecast for Insulin Pen Users (Numbers), 2020 – 2025
Figure 10-5: United States – Disposable Insulin Pen Market (Million US$), 2011 – 2019
Figure 10-6: United States – Forecast for Disposable Insulin Pen Market (Million US$), 2020 – 2025
Figure 10-7: United States – Disposable Insulin Pen Users (Numbers), 2011 – 2019
Figure 10-8: United States – Forecast for Disposable Insulin Pen Users (Numbers), 2020 – 2025
Figure 10-9: United States – Reusable Insulin Pen Market (Million US$), 2011 – 2019
Figure 10-10: United States – Forecast for Reusable Insulin Pen Market (Million US$), 2020 – 2025
Figure 10-11: United States – Reusable Insulin Pen Users (Numbers), 2011 – 2019
Figure 10-12: United States – Forecast for Reusable Insulin Pen Users (Numbers), 2020 – 2025
Figure 10-13: United States – Smart Insulin Pen Market (Million US$), 2011 – 2019
Figure 10-14: United States – Forecast for Smart Insulin Pen Market (Million US$), 2020 – 2025
Figure 10-15: United States – Smart Insulin Pen Users (Numbers), 2011 – 2019
Figure 10-16: United States – Forecast for Smart Insulin Pen Users (Numbers), 2020 – 2025
Figure 10-17: United States – Insulin Pen Needle Market (Million US$), 2011 – 2019
Figure 10-18: United States – Forecast for Insulin Pen Needle Market (Million US$), 2020 – 2025
Figure 11-1: USA – Insulin Pump Market (US$ Million), 2011 – 2019
Figure 11-2: USA– Forecast for Insulin Pump Market (US$ Million), 2020 – 2025
Figure 11-3: United States – Insulin Pump Type 1 Market (Million US$), 2011 – 2019
Figure 11-4: United States – Forecast for Insulin Pump Type 1 Market (Million US$), 2020 – 2025
Figure 11-5: United States – Insulin Pump Type 2 Market (Million US$), 2011 – 2019
Figure 11-6: United States – Forecast for Insulin Pump Type 2 Market (Million US$), 2020 – 2025
Figure 12-1: Global – B. Braun Melsungen AG Revenue (Million US$), 2014 – 2019
Figure 12-2: Global – Forecast for B. Braun Melsungen AG Revenue (Million US$), 2020 – 2025
Figure 12-3: Global – Eli Lilly and Company Revenue (Million US$), 2014 – 2019
Figure 12-4: Global – Forecast for Eli Lilly and Company Revenue (Million US$), 2020 – 2025
Figure 12-5: Global – Artsana S.p.A. Revenue (Million US$), 2016 – 2019
Figure 12-6: Global – Forecast for Artsana S.p.A. Revenue (Million US$), 2020 – 2025
Figure 12-7: Global – Becton, Dickinson and Company Revenue (Million US$), 2014 – 2019
Figure 12-8: Global – Forecast for Becton, Dickinson and Company Revenue (Million US$), 2020 – 2025
Figure 12-9: Global – Novo Nordisk A/S Revenue (Million US$), 2015 – 2019
Figure 12-10: Global – Forecast for Novo Nordisk A/S Revenue (Million US$), 2020 – 2026
Figure 12-11: Global – Owen Mumford Ltd. Revenue (Million US$), 2011 – 2019
Figure 12-12: Global – Forecast for Owen Mumford Ltd. Revenue (Million US$), 2020 – 2026
Figure 12-13: Global – Ypsomed AG Revenue (Million US$), 2013 – 2019
Figure 13-1: Global – Medtronic Insulin Pump Revenue (Million US$), 2014 – 2019
Figure 13-2: Global – Forecast for Medtronic Insulin Pump Revenue (Million US$), 2019 – 2025
Figure 13-3: Global – Insulet Corporation Insulin Pump Revenue (Million US$), 2014 – 2019
Figure 13-4: Global – Forecast for Insulet Corporation Insulin Pump Revenue (Million US$), 2020 – 2025
Figure 14-1: Global - LifeScan SMBG Revenue (Million US$), 2014 – 2019
Figure 14-2: Global - Forecast for LifeScan SMBG Revenue (Million US$), 2020 – 2025
Figure 14-3: Global - Abbott Laboratories Diabetes Care Revenue (Million US$), 2014– 2019
Figure 14-4: Global - Forecast for Abbott Laboratories Diabetes Care Revenue (Million US$), 2020– 2025


List of Tables


List of Tables:

Table 4-4_1: United States - Estimated Spending for Pre-diabetes and Diabetes by the Federal Governmentand States (US$ Billion), 2011 – 2020
Table 7_1: United States – Diabetic Market Share by Types (Percent), 2013 – 2019
Table 7_2: United States – Forecast for Diabetic Market Share by Types (Percent), 2020 - 2025
Table 8_1: Features of Selected CGM Systems Available in the United States
Table 11_1: United States – Animas Vibe Differentiation Features
Table 11_2: United States – Medtronic 530G with Enlite Differentiation Features
Table 11_3: United States – Insulet OmniPod Differentiation Features
Table 11_4: United States – Tandem t: slim Differentiation Features
Table 11_5: United States – Roche Accu-Chek Combo Differentiation Features
Table 11_6: Blue Cross and Blue Shield - Comparison of Benefits between Standard Option and Basic Option
Table 11_7: Blue Cross and Blue Shield – Insulin Pump Coverage
Table 13_1: Medtronic – Latest Insulin Pump Products
Table 13_2: Acquisitions by Medtronic
Table 13_3: Insulet Corporation – Latest Products
Table 14_1: Acquisitions by Abbott